Basic Information
| LncRNA/CircRNA Name | SNHG16 |
| Synonyms | NA |
| Region | GRCh38_17:76557766-76565348 |
| Ensemble | ENSG00000163597 |
| Refseq | NR_038108 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | multiple myeloma |
| ICD-0-3 | C42.1 |
| Methods | qRT-PCR, Western blot |
| Sample | MM tissues,cell lines (RPMI-8226 and NCI-H929) |
| Expression Pattern | up-regulated |
| Function Description | repression of miR-342-3p could rescue the effect of SNHG16 knockdown on MM cell proliferation, cycle arrest, apoptosis, and related protein expression. |
| Pubmed ID | 32025219 |
| Year | 2020 |
| Title | Knockdown of?lncRNA SNHG16 suppresses multiple myeloma cell proliferation by?sponging miR-342-3p |
External Links
| Links for SNHG16 | GenBank HGNC NONCODE |
| Links for multiple myeloma | OMIM COSMIC |